Shipments of Duchenne Gene Therapy to Resume After FDA Review of Patient Death

(MedPage Today) — Drugmaker Sarepta Therapeutics said it would resume shipping its gene therapy for some patients, following a brief pause requested by regulators.
The FDA said it recommended lifting the hold for young patients with Duchenne…